Abstract
COVID-19 pandemic led to rapid development & deployment of vaccines to curb its spread. While these vaccines have saved millions of lives, there have been growing concerns about rare but serious side effects, like heart complications, particularly myocarditis & increased risk of heart attacks. This paper explores possible link between COVID-19 vaccines, especially mRNA vaccines, & cardiovascular risks, focusing on potential causes, underlying mechanisms, & preventive measures. It also emphasizes importance of balancing the benefits of vaccination against these rare side effects and discusses strategies for minimizing heart attack risks post-vaccination. AstraZeneca's Covishield vaccine, a key player in the global fight against COVID-19, has been associated with rare but serious side effects, such as vaccine-induced thrombotic thrombocytopenia (VITT). This paper delves into the nature of these side effects, their prevalence, and whether individuals should be concerned about receiving the vaccine. The risk-benefit analysis overwhelmingly supports vaccination, but the concerns raised by these rare events merit careful consideration, especially in certain populations. This paper underscores the need for balancing the benefits of COVID-19 vaccination with the potential risks and highlights the importance of preventive measures to safeguard those at risk of heart complications. The paper aims to provide a focus and understanding for the public to change their lifestyles; food habits in order to prevent issues related to cardiovascular system.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call